Cargando…

Risk and Prognosis of Thyroid Cancer in Patients with Graves’ Disease: An Umbrella Review

SIMPLE SUMMARY: Graves’ disease (GD) is the most common cause of thyrotoxicosis due to autoimmune hyperthyroidism, especially in women. This umbrella review aimed to provide an evidence-based summary of epidemiological studies conducted on the association between GD and the risk of developing thyroi...

Descripción completa

Detalles Bibliográficos
Autores principales: Palella, Marco, Giustolisi, Francesca Maria, Modica Fiascaro, Adriana, Fichera, Martina, Palmieri, Antonella, Cannarella, Rossella, Calogero, Aldo E., Ferrante, Margherita, Fiore, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216403/
https://www.ncbi.nlm.nih.gov/pubmed/37345061
http://dx.doi.org/10.3390/cancers15102724
_version_ 1785048289835483136
author Palella, Marco
Giustolisi, Francesca Maria
Modica Fiascaro, Adriana
Fichera, Martina
Palmieri, Antonella
Cannarella, Rossella
Calogero, Aldo E.
Ferrante, Margherita
Fiore, Maria
author_facet Palella, Marco
Giustolisi, Francesca Maria
Modica Fiascaro, Adriana
Fichera, Martina
Palmieri, Antonella
Cannarella, Rossella
Calogero, Aldo E.
Ferrante, Margherita
Fiore, Maria
author_sort Palella, Marco
collection PubMed
description SIMPLE SUMMARY: Graves’ disease (GD) is the most common cause of thyrotoxicosis due to autoimmune hyperthyroidism, especially in women. This umbrella review aimed to provide an evidence-based summary of epidemiological studies conducted on the association between GD and the risk of developing thyroid cancer risk and its prognosis. Strong evidence was found for thyroid cancer risk in GD patients and nodular thyroid disease and mortality risk from thyroid cancer in GD patients, particularly in Europe. However, the results of this umbrella review should be taken with caution; as the evidence comes mainly from retrospective studies, the potential concerns are selection and recall bias. ABSTRACT: Graves’ disease (GD) is an autoimmune disease considered the most common cause of hyperthyroidism. Some studies have investigated its relationship with the risk and prognosis of developing thyroid cancer. Considering that there is no consensus on the relationship between GD and thyroid cancer risk, this umbrella review aimed to summarize the epidemiologic evidence and evaluate its strength and validity on the associations of GD with thyroid cancer risk and its prognosis. This umbrella review was performed using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. We systematically searched PubMed and Scopus from January 2012 to December 2022. The strength of the epidemiological evidence was graded as high, moderate, or weak by the Measurement Tool to Assess Systematic Reviews (AMSTAR-2). “Strong” evidence was found for the risk of thyroid cancer in GD patients with thyroid nodular disease (OR: 5.30; 95% CI 2.43–12) and for the risk of mortality from thyroid cancer in these patients (OR 2.93, 95% CI 1.17–7.37, p = 0.02), particularly in Europe (OR 4.89; 95% CI 1.52–16). The results of this umbrella review should be interpreted with caution; as the evidence comes mostly from retrospective studies, potential concerns are selection and recall bias, and whether the empirically observed association reflects a causal relationship remains an open question.
format Online
Article
Text
id pubmed-10216403
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102164032023-05-27 Risk and Prognosis of Thyroid Cancer in Patients with Graves’ Disease: An Umbrella Review Palella, Marco Giustolisi, Francesca Maria Modica Fiascaro, Adriana Fichera, Martina Palmieri, Antonella Cannarella, Rossella Calogero, Aldo E. Ferrante, Margherita Fiore, Maria Cancers (Basel) Systematic Review SIMPLE SUMMARY: Graves’ disease (GD) is the most common cause of thyrotoxicosis due to autoimmune hyperthyroidism, especially in women. This umbrella review aimed to provide an evidence-based summary of epidemiological studies conducted on the association between GD and the risk of developing thyroid cancer risk and its prognosis. Strong evidence was found for thyroid cancer risk in GD patients and nodular thyroid disease and mortality risk from thyroid cancer in GD patients, particularly in Europe. However, the results of this umbrella review should be taken with caution; as the evidence comes mainly from retrospective studies, the potential concerns are selection and recall bias. ABSTRACT: Graves’ disease (GD) is an autoimmune disease considered the most common cause of hyperthyroidism. Some studies have investigated its relationship with the risk and prognosis of developing thyroid cancer. Considering that there is no consensus on the relationship between GD and thyroid cancer risk, this umbrella review aimed to summarize the epidemiologic evidence and evaluate its strength and validity on the associations of GD with thyroid cancer risk and its prognosis. This umbrella review was performed using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. We systematically searched PubMed and Scopus from January 2012 to December 2022. The strength of the epidemiological evidence was graded as high, moderate, or weak by the Measurement Tool to Assess Systematic Reviews (AMSTAR-2). “Strong” evidence was found for the risk of thyroid cancer in GD patients with thyroid nodular disease (OR: 5.30; 95% CI 2.43–12) and for the risk of mortality from thyroid cancer in these patients (OR 2.93, 95% CI 1.17–7.37, p = 0.02), particularly in Europe (OR 4.89; 95% CI 1.52–16). The results of this umbrella review should be interpreted with caution; as the evidence comes mostly from retrospective studies, potential concerns are selection and recall bias, and whether the empirically observed association reflects a causal relationship remains an open question. MDPI 2023-05-11 /pmc/articles/PMC10216403/ /pubmed/37345061 http://dx.doi.org/10.3390/cancers15102724 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Systematic Review
Palella, Marco
Giustolisi, Francesca Maria
Modica Fiascaro, Adriana
Fichera, Martina
Palmieri, Antonella
Cannarella, Rossella
Calogero, Aldo E.
Ferrante, Margherita
Fiore, Maria
Risk and Prognosis of Thyroid Cancer in Patients with Graves’ Disease: An Umbrella Review
title Risk and Prognosis of Thyroid Cancer in Patients with Graves’ Disease: An Umbrella Review
title_full Risk and Prognosis of Thyroid Cancer in Patients with Graves’ Disease: An Umbrella Review
title_fullStr Risk and Prognosis of Thyroid Cancer in Patients with Graves’ Disease: An Umbrella Review
title_full_unstemmed Risk and Prognosis of Thyroid Cancer in Patients with Graves’ Disease: An Umbrella Review
title_short Risk and Prognosis of Thyroid Cancer in Patients with Graves’ Disease: An Umbrella Review
title_sort risk and prognosis of thyroid cancer in patients with graves’ disease: an umbrella review
topic Systematic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216403/
https://www.ncbi.nlm.nih.gov/pubmed/37345061
http://dx.doi.org/10.3390/cancers15102724
work_keys_str_mv AT palellamarco riskandprognosisofthyroidcancerinpatientswithgravesdiseaseanumbrellareview
AT giustolisifrancescamaria riskandprognosisofthyroidcancerinpatientswithgravesdiseaseanumbrellareview
AT modicafiascaroadriana riskandprognosisofthyroidcancerinpatientswithgravesdiseaseanumbrellareview
AT ficheramartina riskandprognosisofthyroidcancerinpatientswithgravesdiseaseanumbrellareview
AT palmieriantonella riskandprognosisofthyroidcancerinpatientswithgravesdiseaseanumbrellareview
AT cannarellarossella riskandprognosisofthyroidcancerinpatientswithgravesdiseaseanumbrellareview
AT calogeroaldoe riskandprognosisofthyroidcancerinpatientswithgravesdiseaseanumbrellareview
AT ferrantemargherita riskandprognosisofthyroidcancerinpatientswithgravesdiseaseanumbrellareview
AT fioremaria riskandprognosisofthyroidcancerinpatientswithgravesdiseaseanumbrellareview